XML 121 R20.htm IDEA: XBRL DOCUMENT v3.25.0.1
Other Balance Sheet Details
 12 Months Ended
Dec. 31, 2024
Other Balance Sheet Details [Abstract]  
Other Balance Sheet Details Other Balance Sheet Details
Inventory consisted of the following:
December 31,
(in millions)20242023
Raw materials$33.7 $21.5 
Work in process10.9 9.7 
Finished goods12.8 12.3 
57.4 43.5 
Less inventory reserves
— (5.2)
Total inventory$57.4 $38.3 
Property and equipment, net, consisted of the following:
December 31,
(in millions)20242023
Tenant improvements$35.9 $38.1 
Scientific equipment95.7 79.6 
Computer equipment38.9 25.2 
Furniture and fixtures18.6 10.9 
189.1 153.8 
Less accumulated depreciation(106.5)(83.0)
Total property and equipment, net$82.6 $70.8 
Accounts payable and accrued liabilities consisted of the following:
December 31,
(in millions)20242023
Sales rebates and reserves$144.2 $139.3 
Accrued employee related costs107.5 86.2 
Accrued development costs50.8 44.3 
Current branded prescription drug fee49.2 45.7 
Accounts payable and other accrued liabilities110.0 133.3 
Total accounts payable and accrued liabilities$461.6 $448.8 
Other noncurrent liabilities consisted of the following:
December 31,
(in millions)20242023
Noncurrent income taxes payable
$160.7 $96.0 
Other noncurrent liabilities5.5 10.3 
Total other noncurrent liabilities$166.2 $106.3 
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown on the consolidated statements of cash flows.
December 31,
(in millions)20242023
Cash and cash equivalents$233.0 $251.1 
Restricted cash included in other noncurrent assets
8.0 8.0 
Total cash, cash equivalents, and restricted cash$241.0 $259.1